Continuation of Research and Development Activities
First written in FY2017-Q1. 25 of 34 entries say "Restated". Latest entry: 2026-08-07.
45 other companies' latest entry also says "Advanced".
- 2026-08-07AdvancedFinancial results briefing materials
「Construction approved for "RIX Okagaki Lab," an onshore aquaculture facility serving both as a demonstration-testing site and showroom」
Previously disclosed development of onshore aquaculture became more concrete with the decision to build the Okagaki Lab, scheduled to open in the first half of 2027, and a fiscal 2030 equipment-sales target of ¥2.0 billion. - FY2026AdvancedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥336 million. Drawing on its proprietary technologies, including precision cleaning technology centered on fluid-control technology, tribology technology and thermal-fluid analysis, as well as accumulated experimental data, the Group is working with its manufacturing and sales divisions, partner companies and public research institutions to resolve technical challenges in each business.」
R&D expenses totaled ¥336 million, and the company is addressing technical challenges in precision cleaning, tribology and thermal-fluid analysis, among other areas, based at the Co-Creation Center. The company also described development of hydrogen-environment creep testing equipment, land-based aquaculture systems and continuous cell-culture equipment. - FY2026-H1RestatedAnnual report
「R&D expenses for the current interim consolidated accounting period totaled ¥159 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
The company disclosed R&D expenses of ¥159 million and continued to state that there were no material changes in the status of its R&D activities. - FY2025AdvancedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥317 million. The Group's R&D division has a total staff of 25 and, from the RIX Co-Creation Center opened in November 2024, is promoting collaborative R&D with startups, business partners, universities and research institutions.」
R&D expenses totaled ¥317 million, the R&D division had a staff of 25, and industry-academia and intercompany collaboration based at the Co-Creation Center opened in November 2024 took concrete form. - FY2025-H1RestatedAnnual report
「R&D expenses for the current interim consolidated accounting period totaled ¥100 million. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
The company disclosed R&D expenses of ¥100 million and continued to state that there were no material changes in the status of its R&D activities. - FY2024AdvancedAnnual report
「Since October 2023, the Group's R&D activities have been conducted by the Technology Development Division and the Digital Development Division, with a total staff of 22.」
The R&D organization was reorganized into the Technology Development Division and the Digital Development Division, with 22 employees working on technical challenges, DX, and the development of automated and labor-saving products. - FY2024-Q3RestatedAnnual report
「R&D expenses for the third quarter of the current cumulative consolidated period totaled ¥134 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company continued to state that there were no material changes in its R&D activities and disclosed R&D expenses of ¥134 million. - FY2024-Q2RestatedAnnual report
「R&D expenses for the second quarter of the current cumulative consolidated period totaled ¥89 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥89 million for the cumulative second quarter and continued to state that there were no material changes in its R&D activities. - FY2024-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current cumulative consolidated period totaled ¥45 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company continued to state that there were no material changes in its R&D activities and disclosed R&D expenses of ¥45 million. - FY2023AdvancedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥178 million. In its particle-size reduction equipment business, the Group is working to commercialize practical systems capable of processing large volumes, develop nozzles for new applications, and develop nanocarbon and composite particles.」
R&D expenses totaled ¥178 million, and the company is advancing development of practical large-volume systems, nozzles for new applications, nanocarbon and composite particles. The company also described development of autonomous mobile robots and IoT products, as well as an award from the Minister of the Environment. - FY2023-Q3RestatedAnnual report
「R&D expenses for the third quarter of the current cumulative consolidated period totaled ¥130 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥130 million for the cumulative third quarter and continued to state that there were no material changes in its R&D activities. - FY2023-Q2RestatedAnnual report
「R&D expenses for the second quarter of the current cumulative consolidated period totaled ¥83 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company continued to state that there were no material changes in its R&D activities and disclosed R&D expenses of ¥83 million. - FY2023-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current cumulative consolidated period totaled ¥39 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company continued to state that there were no material changes in its R&D activities and disclosed R&D expenses of ¥39 million. - FY2022-Q3RestatedAnnual report
「R&D expenses for the third quarter of the current cumulative consolidated period totaled ¥126 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company continued to state that there were no material changes in its R&D activities and disclosed R&D expenses of ¥126 million. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the six months ended the second quarter were ¥77 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」
The company continued to state that there were no material changes in its R&D activities and disclosed R&D expenses of ¥77 million for the second cumulative quarter. - FY2022-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current cumulative consolidated period totaled ¥36 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company continued to state that there were no material changes in its R&D activities and disclosed R&D expenses of ¥36 million. - FY2021AdvancedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥150 million. For its wet particle-size reduction systems, the Group is pursuing the development of new applications and working to commercialize practical systems capable of processing large volumes.」
The company spent ¥150 million on R&D and described specific development activities, including new applications for wet particle-size reduction systems, commercialization of a practical large-volume system, and the transition of FRP pumps to regular production. - FY2021-Q3RestatedAnnual report
「R&D expenses for the third quarter of the current cumulative consolidated period totaled ¥109 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥109 million and continued to state that there were no material changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「R&D expenses for the second quarter of the current cumulative consolidated period totaled ¥71 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥71 million and continued to state that there were no material changes in the status of its R&D activities. - FY2021-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current cumulative consolidated period totaled ¥35 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥35 million and continued to state that there were no material changes in its R&D activities. - FY2020-Q3RestatedAnnual report
「R&D expenses for the third quarter of the current cumulative consolidated period totaled ¥110 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥110 million and continued to state that there were no material changes in the status of its R&D activities. - FY2020-Q2RestatedAnnual report
「R&D expenses for the second quarter of the current cumulative consolidated period totaled ¥74 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥74 million and continued to state that there were no material changes in the status of its R&D activities. - FY2020-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current cumulative consolidated period totaled ¥36 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥36 million and stated that there were no material changes in the status of its R&D activities. - FY2019AdvancedAnnual report
「The Group's total R&D expenses for the current consolidated fiscal year were ¥148 million. For its wet particle-size reduction systems, the Group is working to improve particle dispersion and reduce material loss, while also pursuing the development of new applications.」
In addition to R&D expenses of ¥148 million, the company described specific activities involving wet particle-size reduction systems, rotary joints, FRP pumps and wear-resistant plates, including performance improvements, the development of new materials and applications, and the transition from sample production to regular production. - FY2019-Q3RestatedAnnual report
「R&D expenses for the third quarter of the current cumulative consolidated period totaled ¥110 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥110 million and stated that there were no material changes in the status of its R&D activities. - FY2019-Q2RestatedAnnual report
「R&D expenses for the second quarter of the current cumulative consolidated period totaled ¥72 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥72 million and stated that there were no material changes in the status of its R&D activities. - FY2019-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current cumulative consolidated period totaled ¥35 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥35 million and stated that there were no material changes in the status of its R&D activities. - FY2018-Q3RestatedAnnual report
「R&D expenses for the third quarter of the current cumulative consolidated period totaled ¥114 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥114 million and stated that there were no material changes in the status of its R&D activities. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the six months ended the second quarter were ¥77 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥77 million for the second quarter of the current cumulative consolidated period. - FY2018-Q1RestatedAnnual report
「R&D expenses for the first quarter of the current cumulative consolidated period totaled ¥40 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company disclosed R&D expenses of ¥40 million and stated that there were no material changes in the status of its R&D activities. - FY2017AdvancedAnnual report
「During the current consolidated fiscal year, the Company newly developed a nozzle for cellulose disintegration in its nanoparticle equipment business. It also developed a new large-scale wet particle-size reduction system for mass-production lines. In addition, the division related to Micro Ice Jet (MIJ), which mixes purified water into compressed air, developed a compact nozzle with reduced particle generation for cleaning applications in the semiconductor manufacturing equipment industry.」
In addition to disclosing R&D expenses of ¥162 million, the company described its development of a new nozzle, a large-scale wet particle-size reduction system, and a compact nozzle with reduced particle generation. - FY2017-Q3RestatedAnnual report
「R&D expenses for the third quarter of the current cumulative consolidated period totaled ¥125 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥125 million for the third quarter of the current cumulative consolidated period. - FY2017-Q2RestatedAnnual report
「R&D expenses for the second quarter of the current cumulative consolidated period totaled ¥89 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥89 million for the second quarter of the current cumulative consolidated period. - FY2017-Q1First statedAnnual report
「R&D expenses for the first quarter of the current cumulative consolidated period totaled ¥53 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current cumulative consolidated period.」
The company stated that there were no material changes in its R&D activities and disclosed total R&D expenses for the quarter.